Targeting the Mitochondrial Protein VDAC1 as a Potential Therapeutic Strategy in ALS

por Shteinfer-Kuzmine, Anna, Argueti-Ostrovsky, Shirel, Leyton-Jaimes, Marcel F., Anand, Uttpal, Abu-Hamad, Salah, Zalk, Ran, Shoshan-Barmatz, Varda, Israelson, Adrian
Publicado 2022

Empty mesoporous silica particles significantly delay disease progression and extend survival in a mouse model of ALS

por Leyton-Jaimes, Marcel F., Ivert, Patrik, Hoeber, Jan, Han, Yilin, Feiler, Adam, Zhou, Chunfang, Pankratova, Stanislava, Shoshan-Barmatz, Varda, Israelson, Adrian, Kozlova, Elena N.
Publicado 2020